HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A M Carella Selected Research

Diuretics

9/2007[Therapeutic options for metabolic syndrome in obese patients].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A M Carella Research Topics

Disease

5Neoplasms (Cancer)
08/2012 - 02/2000
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2012 - 01/2000
4Graft vs Host Disease (Graft-Versus-Host Disease)
06/2011 - 02/2000
3Hodgkin Disease (Hodgkin's Disease)
08/2018 - 12/2000
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2017 - 03/2000
3Multiple Myeloma
01/2016 - 10/2011
3Leukemia
06/2010 - 01/2000
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2014 - 02/2014
2Breast Neoplasms (Breast Cancer)
10/2007 - 10/2007
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
07/2017
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
07/2017
1Neutropenia
03/2013
1Anemia
03/2013
1Infections
03/2013
1Thrombotic Thrombocytopenic Purpura
06/2008
1Insulin Resistance
09/2007
1Weight Gain
09/2007
1Weight Loss (Weight Reduction)
09/2007
1Dyslipidemias (Dyslipidemia)
09/2007
1Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2000
1Lymphoma (Lymphomas)
12/2000
1Body Weight (Weight, Body)
06/2000
1Inborn Genetic Diseases (Disease, Hereditary)
03/2000
1Hematologic Neoplasms (Hematological Malignancy)
02/2000

Drug/Important Bio-Agent (IBA)

2Rituximab (Mabthera)FDA Link
12/2014 - 06/2008
2Lenalidomide (CC 5013)FDA Link
03/2013 - 10/2011
2fludarabineIBA
01/2001 - 12/2000
1Brentuximab VedotinIBA
08/2018
1Immune Checkpoint InhibitorsIBA
08/2018
1Azacitidine (5 Azacytidine)FDA Link
07/2017
1Bortezomib (Velcade)FDA Link
01/2016
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
02/2014
1Melphalan (Alkeran)FDA LinkGeneric
03/2013
1Clarithromycin (Biaxin)FDA LinkGeneric
08/2012
1Tyrosine Kinase InhibitorsIBA
08/2012
1Monoclonal AntibodiesIBA
06/2011
1Phosphotransferases (Kinase)IBA
06/2010
1Fibric Acids (Fibrates)IBA
09/2007
1AldosteroneIBA
09/2007
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
09/2007
1Antihypertensive Agents (Antihypertensives)IBA
09/2007
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
09/2007
1DiureticsIBA
09/2007
1IndapamideFDA LinkGeneric
09/2007
1LipidsIBA
09/2007
1Metformin (Glucophage)FDA LinkGeneric
09/2007
1SodiumIBA
09/2007
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
09/2007
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2007
1Anti-Obesity Agents (Antiobesity Drugs)IBA
09/2007
1AcarboseFDA LinkGeneric
09/2007
1ThiazolidinedionesIBA
09/2007
1Angiotensin Receptor AntagonistsIBA
09/2007
1Alemtuzumab (Campath)FDA Link
01/2004
1SteroidsIBA
01/2004
1Cytarabine (Cytosar-U)FDA LinkGeneric
01/2001
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2001
1IceIBA
01/2001
1Hydroxyurea (Hydrea)FDA LinkGeneric
01/2001
1Methotrexate (Mexate)FDA LinkGeneric
12/2000
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2000
1Cyclosporine (Ciclosporin)FDA LinkGeneric
12/2000
1roquinimexIBA
06/2000
1Biological ProductsIBA
03/2000

Therapy/Procedure

5Therapeutics
08/2018 - 02/2000
5Autologous Transplantation
04/2015 - 01/2000
5Homologous Transplantation
06/2011 - 02/2000
3Stem Cell Transplantation
07/2017 - 02/2000
3Hematopoietic Stem Cell Transplantation
06/2011 - 03/2000
2Salvage Therapy
11/2001 - 01/2001
1Aftercare (After-Treatment)
07/2017
1Hematopoietic Stem Cell Mobilization
10/2011
1Bariatric Surgery
09/2007
1Drug Therapy (Chemotherapy)
12/2000